No Prescription |
 |
 | ||
|
CELIN Ascorbicap |
|
| ||
No Prescription » Prescription Drugs 4 » CELIN Ascorbicap Ascorbic acid (vitamin C) may be used to prevent low body levels (deficiency) of this vitamin. Ascorbic acid is needed to maintain the health of skin cartilage teeth and blood vessels and to promote proper bone growth. Most people who eat a normal diet do not need extra ascorbic acid.Vitamin C deficiency may occur in certain health conditions (e.g. poor nutrition diet lacking citrus fruit/vegetables alcoholism). Serious ascorbic acid deficiency may cause a condition called scurvy resulting in bleeding problems tooth loss and heart problems among others.Ascorbic acid is also used to help preserve the health of body cells (as an antioxidant).How to use Ascorbic Acid OralTake this vitamin by mouth usually 1 to 2 times daily. If this vitamin is prescribed by your doctor take exactly as directed. Take each dose with a full glass (8 ounces or 240 milliliters) of water. Do not lie down for at least 30 minutes after taking a dose. If you are taking the chewable tablets or wafers chew them thoroughly. If you are taking the delayed-release capsules or tablets swallow them whole. Do not crush or chew them. If you are taking the lozenges place the lozenge in your mouth and allow it to slowly dissolve. If you are taking the powder mix it thoroughly in the proper amount of liquid and stir well. Drink all of the liquid immediately. Do not prepare a supply for future use. If you are using a liquid or powder form carefully measure your dose using a medication-measuring device or spoon. Do not use a household spoon because you may not get the correct dose.Dosage is based on your medical condition and response to treatment.Use this vitamin regularly to get the most benefit from it. To help you remember take it at the same time(s) each day.If your doctor has prescribed this product to treat a specific problem tell him/her if your condition persists or worsens. Buy CELIN Ascorbicap and other Prescription Drugs 4 products online at Medstore. 430
About CELIN Ascorbicap: Product Type: Prescription Drugs 4 CELIN ( Ascorbicap Ce-Vi-Sol Cecon Cetane Cevalin CeviBid Flavorcee Vita-c Vitamin C Generic Ascorbic acid ) CELIN (Ascorbicap Ce-Vi-Sol Cecon Cetane Cevalin CeviBid Flavorcee Vita-c Vitamin C Generic Ascorbic acid) Ascorbicap Ce-Vi-Sol Cecon Cetane Cevalin CeviBid Flavorcee Vita-c Vitamin C Generic Ascorbic acid 500mg Tabs 100 (10 x 10) Ascorbicap Ce-Vi-Sol Cecon Cetane Cevalin CeviBid Flavorcee Vita-c Vitamin C Generic Ascorbic acid CELIN
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
